The pharma group’s chief executive, David Ricks, has told the Financial Times that the authorities should examine the deal closely, given that Catalent’s client roster includes “in excess of ...

Novo Nordisk has taken the bold step of buying three manufacturing facilities from contract development and manufacturing organisation Catalent as ... Neurotech Pharma's cell therapy Encelto ...

Craig-Hallum analyst Greg Palm maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today. The company’s shares opened today at $5.65. See what stocks are receiving ...

Other paths for organic growth include increasing penetration in convenience stores with their loyalty and payments products (just launched), offering PAR’s existing customer base POS solutions ...

Pete Marocco, deputy administrator-designate at the U.S. Agency for International Development (USAID), arrives to meet with members of Congress to discuss foreign assistance, on Capitol Hill in ...

Unvaccinated New Mexico adult tests positive for measles after death A New Mexico resident who has died, tested positive for measles, the state health department said on Thursday, marking the ...

John Chiminski brings more than three decades of leadership in healthcare and pharma services. He served as CEO of Catalent from 2009 to 2015, then as Chair and CEO from 2016 through 2022, and as ...

Symbiance Pharma Solutions Private Limited is an Indian Non-Government Company. It's a private company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 5.0 ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

IPC Indice de Precios Y Cotizaciones 52,816.43 107.03 0.20% ...

Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial Information is based on numbers. Note :Financial ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,776.56 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...